AccuStem Sciences Limited
ACMSY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2,089 | $1,654 | $1,487 |
| - Cash | $14 | $31 | $36 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $2,058 | $1,618 | $1,482 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$399 | -$401 | -$440 | -$261 |
| % Margin | – | – | – | – |
| Net Income | -$400 | -$401 | -$440 | -$372 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.02 | -0.02 | -0.03 | -0.03 |
| % Growth | 0% | 33.3% | 0% | – |
| Operating Cash Flow | -$604 | -$269 | -$290 | -$237 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$604 | -$269 | -$290 | -$237 |